PubRank

Ralph P Mason

Author PubWeight™ 82.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 2005 5.51
2 Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res 2008 3.99
3 Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006 3.98
4 Molecular imaging of hypoxia. J Nucl Med 2008 2.61
5 19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr Med Chem 2005 1.79
6 Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 2004 1.65
7 Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg Med Chem Lett 2004 1.57
8 Development of aliphatic biodegradable photoluminescent polymers. Proc Natl Acad Sci U S A 2009 1.54
9 On the potential for molecular imaging with Cerenkov luminescence. Opt Lett 2010 1.33
10 Measuring changes in tumor oxygenation. Methods Enzymol 2004 1.30
11 Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI. FASEB J 2008 1.26
12 Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clin Cancer Res 2008 1.23
13 Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice. PLoS One 2009 1.18
14 Tumor physiologic response to combretastatin A4 phosphate assessed by MRI. Int J Radiat Oncol Biol Phys 2005 1.16
15 Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia 2003 1.15
16 Comparison of 1H blood oxygen level-dependent (BOLD) and 19F MRI to investigate tumor oxygenation. Magn Reson Med 2009 1.10
17 Novel NMR approach to assessing gene transfection: 4-fluoro-2-nitrophenyl-beta-D-galactopyranoside as a prototype reporter molecule for beta-galactosidase. Magn Reson Med 2004 1.07
18 Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response. Magn Reson Med 2013 1.04
19 Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor. Radiat Res 2003 1.04
20 Novel 1H NMR approach to quantitative tissue oximetry using hexamethyldisiloxane. Magn Reson Med 2006 1.03
21 Tumour oxygen dynamics measured simultaneously by near-infrared spectroscopy and 19F magnetic resonance imaging in rats. Phys Med Biol 2005 1.03
22 Blood oxygenation level-dependent (BOLD) contrast magnetic resonance imaging (MRI) for prediction of breast cancer chemotherapy response: a pilot study. J Magn Reson Imaging 2012 1.02
23 The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. Int J Cancer 2007 1.02
24 Imaging beta-galactosidase activity using 19F chemical shift imaging of LacZ gene-reporter molecule 2-fluoro-4-nitrophenol-beta-D-galactopyranoside. Magn Reson Imaging 2006 1.02
25 New frontiers and developing applications in 19F NMR. Prog Nucl Magn Reson Spectrosc 2012 1.02
26 Near-infrared spectroscopy and imaging of tumor vascular oxygenation. Methods Enzymol 2004 1.01
27 Novel NMR platform for detecting gene transfection: synthesis and evaluation of fluorinated phenyl beta-D-galactosides with potential application for assessing LacZ gene expression. Bioconjug Chem 2004 1.01
28 Imaging beta-galactosidase activity in human tumor xenografts and transgenic mice using a chemiluminescent substrate. PLoS One 2010 0.99
29 Synthesis and evaluation of novel enhanced gene reporter molecules: detection of beta-galactosidase activity using 19F NMR of trifluoromethylated aryl beta-D-galactopyranosides. Bioorg Med Chem 2005 0.99
30 S-Gal, a novel 1H MRI reporter for beta-galactosidase. Magn Reson Med 2010 0.98
31 Proton imaging of siloxanes to map tissue oxygenation levels (PISTOL): a tool for quantitative tissue oximetry. NMR Biomed 2008 0.97
32 Interplay of tumor vascular oxygenation and tumor pO2 observed using near-infrared spectroscopy, an oxygen needle electrode, and 19F MR pO2 mapping. J Biomed Opt 2003 0.97
33 High-throughput quantitative bioluminescence imaging for assessing tumor burden. Methods Mol Biol 2009 0.97
34 Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor. Int J Radiat Oncol Biol Phys 2007 0.97
35 Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent. J Nat Prod 2013 0.95
36 Development of intrinsically photoluminescent and photostable polylactones. Adv Mater 2014 0.94
37 Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3T. NMR Biomed 2012 0.94
38 Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. Int J Radiat Oncol Biol Phys 2002 0.94
39 Dynamic response of breast tumor oxygenation to hyperoxic respiratory challenge monitored with three oxygen-sensitive parameters. Appl Opt 2003 0.94
40 Exploring feasibility of multicolored CdTe quantum dots for in vitro and in vivo fluorescent imaging. J Nanosci Nanotechnol 2008 0.94
41 Physical principles of quantitative nuclear magnetic resonance oximetry. Front Biosci 2008 0.93
42 Synthesis and evaluation of a novel gene reporter molecule: detection of beta-galactosidase activity using 19F NMR of a fluorinated vitamin B6 conjugate+. Med Chem 2005 0.93
43 A 19F-NMR approach using reporter molecule pairs to assess beta-galactosidase in human xenograft tumors in vivo. NMR Biomed 2008 0.93
44 19F-NMR detection of lacZ gene expression via the enzymic hydrolysis of 2-fluoro-4-nitrophenyl beta-D-galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse. FASEB J 2007 0.91
45 Comparison of BOLD contrast and Gd-DTPA dynamic contrast-enhanced imaging in rat prostate tumor. Magn Reson Med 2004 0.91
46 Continuous low-dose (metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology. Neoplasia 2005 0.90
47 A noninvasive tumor oxygenation imaging strategy using magnetic resonance imaging of endogenous blood and tissue water. Magn Reson Med 2014 0.90
48 Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors. PLoS One 2012 0.89
49 Evaluation of red CdTe and near infrared CdHgTe quantum dots by fluorescent imaging. J Nanosci Nanotechnol 2008 0.87
50 Synthesis and characterization of novel lacZ gene reporter molecules: detection of beta-galactosidase activity by 19F nuclear magnetic resonance of polyglycosylated fluorinated vitamin B6. J Med Chem 2006 0.87
51 Dynamic breast tumor oximetry: the development of prognostic radiology. Technol Cancer Res Treat 2002 0.86
52 Tubulin-destabilizing agent BPR0L075 induces vascular-disruption in human breast cancer mammary fat pad xenografts. PLoS One 2012 0.86
53 In vitro and In vivo Assessment of CdTe and CdHgTe Toxicity and Clearance. J Biomed Nanotechnol 2008 0.86
54 In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to combretastatin A-4-phosphate correlated with therapeutic outcome. Int J Radiat Oncol Biol Phys 2011 0.85
55 Molecular imaging in prostate cancer. J Cell Biochem 2003 0.84
56 Simultaneous measurement of tissue oxygen level-dependent (TOLD) and blood oxygenation level-dependent (BOLD) effects in abdominal tissue oxygenation level studies. J Magn Reson Imaging 2013 0.83
57 Dual 19F/1H MR gene reporter molecules for in vivo detection of β-galactosidase. Bioconjug Chem 2012 0.83
58 Phosphatidylserine-targeted molecular imaging of tumor vasculature by magnetic resonance imaging. J Biomed Nanotechnol 2014 0.82
59 Novel Fe(3+)-Based (1)H MRI β-Galactosidase Reporter Molecules** Chempluschem 2012 0.82
60 GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo. J Biol Inorg Chem 2013 0.81
61 Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate. Am J Ther 2006 0.81
62 Quantitative tissue oxygen measurement in multiple organs using 19F MRI in a rat model. Magn Reson Med 2011 0.81
63 Dynamic contrast enhanced fluorescent molecular imaging of vascular disruption induced by combretastatin-A4P in tumor xenografts. J Biomed Nanotechnol 2014 0.81
64 Upregulation of TRAG3 gene in urothelial carcinoma of the bladder. Int J Cancer 2010 0.81
65 Hexamethyldisiloxane-based nanoprobes for (1) H MRI oximetry. NMR Biomed 2011 0.79
66 Serial non-invasive monitoring of renal disease following immune-mediated injury using near-infrared optical imaging. PLoS One 2012 0.79
67 Novel S-Gal(®) analogs as (1)H MRI reporters for in vivo detection of β-galactosidase. Magn Reson Imaging 2013 0.78
68 In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model. J Vis Exp 2011 0.78
69 Red-shifted emission from 1,2-dioxetane-based chemiluminescent reactions. Luminescence 2014 0.77
70 Tumor oxygen dynamics: comparison of 19F MR EPI and frequency domain NIR spectroscopy. Adv Exp Med Biol 2003 0.76
71 Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization. Bioorg Med Chem 2015 0.76
72 6-Trifluoromethylpyridoxine: novel (19)F NMR pH indicator for in vivo detection. J Med Chem 2012 0.75
73 Mathematical modeling of tumor response to radiation: radio-sensitivity correlation with BOLD, TOLD, ΔR1 and ΔR2* investigated in large Dunning R3327-AT1 rat prostate tumors. Conf Proc IEEE Eng Med Biol Soc 2015 0.75